Dr Aniruddha Chatterjee
Rutherford Discovery Fellow,
Department of Pathology, Dunedin School of Medicine,
University of Otago,
Dr Aniruddha Chatterjee is originally from Berhampore, West Bengal (India), where he completed his schooling.
Aniruddha moved to the southern part of India and completed a BSc (Osmania University, Hyderabad) and MSc degree (VIT University, Vellore) in Biotechnology with first class and distinction.
Following this, Aniruddha came to the University of Otago in New Zealand in 2009, where he commenced his PhD. In his doctoral work, he mapped whole-genome scale DNA methylation patterns and variation in normal human neutrophil cells.
Aniruddha played a leading role in performing the first reduced representation methylation sequencing in human neutrophils, melanoma, and the model organism zebrafish. He has also heavily published on methodology development for DNA methylation and microRNA analysis.
In 2017, Aniruddha was awarded the prestigious Rutherford Discovery Fellowship from the Royal Society of New Zealand to establish this Epigenetics, Disease, and Phenotype Laboratory (EDP).
Outside of work he enjoys dancing, acting, sports, travelling, and music.
Early in 2008, Sue Clark brought a handful of epigenetics researchers from Australia together to form the Australian Epigenetics Alliance. The AEpiA has now grown to a membership of over 600, with members spanning not only Australasia, but the globe. In February 2021, our Victorian local organising committee hosted our eighth flagship Epigenetics conference, online for the first time. Our NSW team is now busy preparing for Epigenetics 2022, which will be held in September in Kingscliff, NSW.